Start your free online case review. Call us at 1-888-293-6883.
Legal representatives at RPWB are filing claims on behalf of Columbia locals who have suffered from complications like gastroparesis, ileus/intestinal blockage and a vision disorder called NAION (non-arteritic anterior ischemic optic neuropathy) after taking GLP-1RA medications. These drugs, such as Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, and Zepbound, are used to treat diabetes and aid in weight loss.
Ozempic became publicly available in 2017 as a diabetes medication, but was quickly found to be an effective weight loss treatment. Because of it’s duel use similar drugs were also created. These medications rapidly became used by tens of millions of people. As the use of Ozempic, and similar drugs rises in Columbia, South Carolina, negative side effects have been uncovered. Many users claim the drugs are causing severe gastrointestinal injuries, including gastroparesis or stomach paralysis. Gastroparesis can be a lifelong medical condition where the stomach wall is weakened. This chronic digestive disorder is a serious condition because the weakened stomach has difficulty moving food through the stomach into the small intestine.
Legal regulations require pharmaceutical firms to disclose all potential side effects of their drugs. However, medications like Ozempic fail to mention the risk of gastroparesis despite its common occurrence. This omission is unjust and deceptive to both patients and physicians.
If gastroparesis has affected you or someone you care about after using weight loss drugs, contact us for a complimentary and confidential case assessment. You could be eligible for significant compensation. Pursue justice for yourself and contribute to maintaining the honesty of pharmaceutical marketing to patients and healthcare providers.
We are here, ready to answer any questions you may have about Ozempic and similar drugs. Click HERE to go to our main Ozempic lawsuit page to learn more, or you may call us at 1-866-639-0366.